192 related articles for article (PubMed ID: 2420428)
1. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
Catz I; Warren KG
Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
[TBL] [Abstract][Full Text] [Related]
2. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue.
Warren KG; Catz I
J Neurol Sci; 1993 Apr; 115(2):169-76. PubMed ID: 7683331
[TBL] [Abstract][Full Text] [Related]
4. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
Warren KG; Catz I
J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
[TBL] [Abstract][Full Text] [Related]
5. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
Maimone D; Annunziata P; Cioni C; Leonardi A; Guazzi GC
Acta Neurol Scand; 1994 Oct; 90(4):285-92. PubMed ID: 7530889
[TBL] [Abstract][Full Text] [Related]
7. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis.
Panitch HS; Hooper CJ; Johnson KP
Arch Neurol; 1980 Apr; 37(4):206-9. PubMed ID: 6153890
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.
Warren KG; Catz I
J Neurol Sci; 1988 Dec; 88(1-3):185-94. PubMed ID: 2465390
[TBL] [Abstract][Full Text] [Related]
9. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
Warren KG; Catz I; Johnson E; Mielke B
Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
[TBL] [Abstract][Full Text] [Related]
10. Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations.
Warren KG; Catz I; Jeffrey VM; Carroll DJ
Can J Neurol Sci; 1986 Feb; 13(1):25-30. PubMed ID: 2420429
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapses and subsequent convalescent phases.
Warren KG; Catz I
J Neurol Sci; 1989 Jun; 91(1-2):143-51. PubMed ID: 2473170
[TBL] [Abstract][Full Text] [Related]
12. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
Wajgt A; Górny M
Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
[TBL] [Abstract][Full Text] [Related]
13. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients.
Warren KG; Catz I
J Neurol Sci; 1990 Apr; 96(1):19-27. PubMed ID: 1693669
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
15. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis.
Warren KG; Catz I
J Neuroimmunol; 1993 Mar; 43(1-2):87-96. PubMed ID: 7681451
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis.
Warren KG; Catz I
Ann Neurol; 1986 Jul; 20(1):20-5. PubMed ID: 2427010
[TBL] [Abstract][Full Text] [Related]
17. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
Kasai N; Pachner AR; Yu RK
J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
[TBL] [Abstract][Full Text] [Related]
18. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
[TBL] [Abstract][Full Text] [Related]
19. Myelin basic protein antibodies in the serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients.
Ruutiainen J; Arnadottir T; Molnár G; Salmi A; Frey H
Acta Neurol Scand; 1981 Sep; 64(3):196-206. PubMed ID: 6171986
[TBL] [Abstract][Full Text] [Related]
20. Administration of myelin basic protein synthetic peptides to multiple sclerosis patients.
Warren KG; Catz I
J Neurol Sci; 1995 Nov; 133(1-2):85-94. PubMed ID: 8583237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
